The spectrum of neuromyelitis optica.

By D. Wingerchuk, V. Lennon, C. Lucchinetti, S. Pittock, B. Weinshenker. Lancet Neurology, 2007

2,102 citations recorded by the source corpus.

Subfields: Neurology, Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/3876c6e573f1dcae8e6ef438f371f54352798a90

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Ulf Ziemann
2. B. Weinshenker

In Pathology and Forensic Medicine

1. Jeffrey A. Cohen
2. B. Weinshenker

Citations in the corpus

• MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis (2009, background): “1a ) than in those of age-matched controls or patients with NMO, an inflammatory demyelinating CNS disease with symptoms that considerably overlap those of multiple sclerosis but an etiology distinct from that of multiple sclerosi”
• Aquaporin water channels in the nervous system (2013, neutral): “NMO is a rare inflammatory demy-elinating disease of the CNS that preferentially affects the optic nerves and spinal cord 52,111 , and causes blindness, paralysis and death.”
• International consensus diagnostic criteria for neuromyelitis optica spectrum disorders (2015, neutral): “Neuromyelitis optica (NMO) is an inflammatory CNS disorder distinct from multiple sclerosis (MS).(1,2) It became known as Devic disease following a seminal 1894 report.”
• Clinical presentation and prognosis in MOG-antibody disease: a UK study (2017, background): “…criteria in the Oxford total cohort Of the 53 adults (416 years), 47 fulfilled either the NMO 2006 (Wingerchuk et al., 2006) or NMOSD 2007 (Wingerchuk et al., 2007) criteria but only 17 fulfilled the NMOSD 2015 (Wingerchuk et al., 2015) criteria (because of the requirement for more than…”
• Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients (2012, methodology): “(2007) [17] and known AQP4-Ab serostatus.”
• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (2011, background): “By using the recommended simplified MAGNIMS criteria to demonstrate DIS22 and allowing DIT to be demonstrated by a scan containing both enhancing and nonenhancing lesions in regions of the CNS typical for MS,23 a diagnosis of MS can be made in some CIS patients based on a single MRI.24 The Panel fel”